ACG Clinical Guideline: Alcohol-Associated Liver Disease
- PMID: 38174913
- PMCID: PMC11040545
- DOI: 10.14309/ajg.0000000000002572
ACG Clinical Guideline: Alcohol-Associated Liver Disease
Abstract
Alcohol-associated liver disease (ALD) is the most common cause of advanced hepatic disease and frequent indication for liver transplantation worldwide. With harmful alcohol use as the primary risk factor, increasing alcohol use over the past decade has resulted in rapid growth of the ALD-related healthcare burden. The spectrum of ALD ranges from early asymptomatic liver injury to advanced disease with decompensation and portal hypertension. Compared with those with other etiologies of liver disease, patients with ALD progress faster and more often present at an advanced stage. A unique phenotype of advanced disease is alcohol-associated hepatitis (AH) presenting with rapid onset or worsening of jaundice, and acute on chronic liver failure in severe forms conveying a 1-month mortality risk of 20%-50%. The model for end stage disease score is the most accurate score to stratify AH severity (>20 defined as severe disease). Corticosteroids are currently the only available therapeutic with proven efficacy for patients with severe AH, providing survival benefit at 1 month in 50%-60% of patients. Abstinence of alcohol use, a crucial determinant of long-term outcomes, is challenging to achieve in ALD patients with concurrent alcohol use disorder (AUD). As patients with ALD are rarely treated for AUD, strategies are needed to overcome barriers to AUD treatment in patients with ALD and to promote a multidisciplinary integrated care model with hepatology, addiction medicine providers, and social workers to comprehensively manage the dual pathologies of liver disease and of AUD. Liver transplantation, a definitive treatment option in patients with advanced cirrhosis, should be considered in selected patients with AH, who are unresponsive to medical therapy and have a low risk of relapse to posttransplant alcohol use. Level of evidence and strength of recommendations were evaluated using the Grading of Recommendations, Assessment, Development, and Evaluations system. This guideline was developed under the American College of Gastroenterology Practice Parameters Committee.
Copyright © 2024 by The American College of Gastroenterology.
Similar articles
-
ACG Clinical Guideline: Alcoholic Liver Disease.Am J Gastroenterol. 2018 Feb;113(2):175-194. doi: 10.1038/ajg.2017.469. Epub 2018 Jan 16. Am J Gastroenterol. 2018. PMID: 29336434 Free PMC article.
-
Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians.Clin Ther. 2023 Dec;45(12):1177-1188. doi: 10.1016/j.clinthera.2023.09.016. Epub 2023 Oct 8. Clin Ther. 2023. PMID: 37813775 Review.
-
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).Ann Hepatol. 2019 May-Jun;18(3):518-535. doi: 10.1016/j.aohep.2019.04.005. Epub 2019 Apr 18. Ann Hepatol. 2019. PMID: 31053546 Review.
-
Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder.Clin Gastroenterol Hepatol. 2023 Jul;21(8):2124-2134. doi: 10.1016/j.cgh.2023.02.017. Epub 2023 Feb 27. Clin Gastroenterol Hepatol. 2023. PMID: 36858144 Review.
-
Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin.Liver Transpl. 2024 Feb 1;30(2):200-212. doi: 10.1097/LVT.0000000000000296. Epub 2023 Nov 8. Liver Transpl. 2024. PMID: 37934047
Cited by
-
Evolution of Liver Transplantation Indications: Expanding Horizons.Medicina (Kaunas). 2024 Feb 28;60(3):412. doi: 10.3390/medicina60030412. Medicina (Kaunas). 2024. PMID: 38541138 Free PMC article. Review.
-
Past, Present, and Future Therapies for Alcohol-associated Hepatitis.Clin Ther. 2023 Dec;45(12):1171-1176. doi: 10.1016/j.clinthera.2023.10.013. Epub 2023 Nov 18. Clin Ther. 2023. PMID: 37980219
References
-
- Singal A, Mathurin P. Diagnosis and treatment of alcohol-associated liver disease: A review. JAMA 2021;326(2):165–76. - PubMed
-
- Bataller R, Arab JP, Shah VH. Alcohol-associated hepatitis. N Engl J Med 2022;387(26):2436–48. - PubMed
-
- Yoon Y-H, Chen CM, Yi H-y. Liver Cirrhosis Mortality in the United States: National, State, and Regional Trends, 2000–2011. National Institutes of Health: Arlington, VA, 2014. Report no.: surveillance report #100, December.
-
- Organization WWH. Alcohol 2022. (https://www.who.int/news-room/fact-sheets/detail/alcohol)
-
- Chen CM, Yoon Y-H. Liver cirrhosis mortality in the united states: national, state, and regional trends, 2000–2019. National Institutes of Health: Sterling, VA, 2022. February.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous